Maibeth is one of the founders of Maynard & Gale and formerly served on the Firm’s Board of Directors. Her practice focuses on two areas, Financial Services and Product Liability.
Maibeth represents the financial services industry in commercial litigation and regulatory risk. In this regard, she deals with representatives of the Federal Reserve, the Alabama State Banking Department, the Consumer Financial Protection Bureau, the Justice Department, and the Securities and Exchange Commission, in both routine regulatory matters and special investigations, including responding to grand jury subpoenas. Maibeth has also designed and conducted compliance reviews and assisted financial institutions in writing and revising their policies and procedures.
Maibeth has represented drug and medical device manufacturers for 25 years in product liability cases involving diets drugs, phenylpropanolamine, thimerosal-containing vaccines, hormone replacement therapies, autoimmune disease biologics, contraceptive devices, breast implants, dialyzers, electronic hearing devices, fertility drugs, anti-reflux devices, latex gloves, incubators, component parts of oxygen delivery systems, and anti-nausea drugs.
Her litigation skills and talents have earned her recognition as a Fellow of the International Academy of Trial Lawyers and a Leading Litigator in Chambers USA: America's Leading Lawyers for Business.
Maibeth received her J.D. from Vanderbilt University School of Law and holds a B.A., summa cum laude, from the University of the South (Sewanee).
"Her depth of experience brings wise judgment and she has a way of spotting the issues before they have presented themselves."
"She is incredibly organized and able to break down complex situations and develop a quick understanding."